Amanda Helms

Ms. Amanda Helms

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2024 in Cells
Verified
Journal Article
Open access
PDF file
AHAmanda Helms
Amanda Helms
JBJennifer S. Brodbelt
Jennifer S. Brodbelt
Glycoproteomics has accelerated in recent decades owing to numerous innovations in the analytical workflow. In particular, new mass spectrometry strategies have contributed to inroads in O-glycoproteomics, a field that lags behind N-glycoproteomics due to several unique challenges associated with the complexity of O-glycosylation. This review will focus on progress in sample preparation, enrichment strategies, and MS/MS techniques for the identification and characterization of O-glycoproteins.

22 November 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
AHAmanda Helms
Amanda Helms
VCVincent Chang
Vincent Chang
SMStacy Malaker
Stacy Malaker
JBJennifer S. Brodbelt
Jennifer S. Brodbelt

16 April 2024 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
MGMarion Girod
Marion Girod
DADelphine Arquier
Delphine Arquier
AHAmanda Helms
Amanda Helms
KJKyle Juetten
Kyle Juetten
JBJennifer S. Brodbelt
Jennifer S. Brodbelt
LMLuke MacAleese
Luke MacAleese

22 July 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
VJVirginia K. James
Virginia K. James
BVBradley J. Voss
Bradley J. Voss
AHAmanda Helms
Amanda Helms
MTM. Stephen Trent
M. Stephen Trent
JBJennifer S. Brodbelt
Jennifer S. Brodbelt

25 March 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YDYaokai Duan
Yaokai Duan
MLMichael Lanzillotti
Michael Lanzillotti
DRDylan L. Riggs
Dylan L. Riggs
ANAlbana Nito
Albana Nito
JMJunnichi Mijares
Junnichi Mijares
ZZZhongqi Zhang
Zhongqi Zhang
Background/Objectives: Mass spectrometry-based multi-attribute methods (MAM) have the potential to transform therapeutic protein analysis by enabling comprehensive monitoring of multiple quality attributes in a single assay. However, the widespread adoption of MAM is hindered by significant challenges, most notably artificial oxidation during sample preparation and analysis. This report summarizes long-term operational observations and several case studies that substantiate this concern. Methods: A tryptic digest, high-resolution LC-MS MAM workflow was applied to an Fc-fusion protein and multiple antibody-based therapeutics, with a frozen reference standard analyzed in each run for system suitability and longitudinal trending. Oxidation excursions were investigated by comparing laboratories, consumables, LC-MS configurations, and other method parameters. Results: In a seven-year trending record, apparent total methionine oxidation in the Fc-fusion protein reference standard showed an abrupt, sustained increase (up to ~5-fold); the shift was traced to a specific bag of microcentrifuge-tubes used during buffer exchange and resolved after those tubes were discontinued. In an antibody–drug conjugate, observed methionine oxidation was strongly influenced by the sample preparation procedure. In other antibodies, variability of observed methionine oxidation was attributed to on-column oxidation, which produced a broad and noisy peak that interferes with automated peak integration. EDTA flushing reduced this feature, implicating exposure to metal ions. Conclusions: While advances continue to address many MAM challenges, artificial oxidation remains unpredictable and constitutes a major obstacle to robust implementation in regulated QC environments. Enhanced control strategies and further research are urgently needed to ensure reliable therapeutic protein analysis. Such control strategies include consumable qualification and change control, system suitability/trending using a reference standard, metal management across LC flow path/column lifecycle, reduction of trifluoracetic acid (TFA) exposure, data analysis to safeguard excessive on-column oxidation, etc.

28 May 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
VJVirginia James
Virginia James
BVBradley Voss
Bradley Voss
AHAmanda Helms
Amanda Helms
MTM. Stephen Trent
M. Stephen Trent
JBJennifer S. Brodbelt
Jennifer S. Brodbelt
Gram-negative bacteria develop and exhibit resistance to antibiotics owing to their highly asymmetric outer membrane maintained by a group of six proteins comprising the Mla (maintenance of lipid asymmetry) pathway. Here we investigate the lipid binding preferences of one Mla protein, MlaC, which transports lipids through the periplasm. We used ultraviolet photodissociation (UVPD) to identify and characterize modifications of lipids endogenously bound to MlaC expressed in three different bacteria strains. UVPD was also used to localize lipid binding to MlaC residues 130-140, consistent with the crystal structure reported for lipid-bound MlaC. The impact of removing the bound lipid from MlaC on its structure was monitored based on collision cross section measurements, revealing that the protein unfolded prior to release of the lipid. The lipid selectivity of MlaC was evaluated based on titrimetric experiments, indicating that MlaC bound lipids in various classes (sphingolipids, glycerophospholipids, fatty acids) as long as they possessed no more than two acyl chains.